Protection of mitochondria prevents high-fat diet–induced glomerulopathy and proximal tubular injury

Wang, 2008, Association between obesity and kidney disease: a systematic review and meta-analysis, Kidney Int, 73, 19, 10.1038/sj.ki.5002586 Chertow, 2006, The enlarging body of evidence: obesity and chronic kidney disease, J Am Soc Nephrol, 17, 1501, 10.1681/ASN.2006040327 de Vries, 2014, Fatty kidney: emerging role of ectopic lipid in obesity-related renal disease, Lancet Diabetes Endocrinol, 2, 417, 10.1016/S2213-8587(14)70065-8 Chen, 2006, Podocyte lesions in patients with obesity-related glomerulopathy, Am J Kidney Dis, 48, 772, 10.1053/j.ajkd.2006.07.025 Deji, 2009, Structural and functional changes in the kidneys of high-fat diet-induced obese mice, Am J Physiol Renal Physiol, 296, F118, 10.1152/ajprenal.00110.2008 Shevalye, 2012, Prediabetic nephropathy as an early consequence of the high-calorie/high-fat diet: relation to oxidative stress, Endocrinology, 153, 1152, 10.1210/en.2011-1997 Sun, 2015, Smad3 deficiency protects mice from obesity-induced podocyte injury that precedes insulin resistance, Kidney Int, 88, 286, 10.1038/ki.2015.121 Ruggiero, 2011, High-fat diet induces an initial adaptation of mitochondrial bioenergetics in the kidney despite evident oxidative stress and mitochondrial ROS production, Am J Physiol Endocrinol Metab, 300, E1047, 10.1152/ajpendo.00666.2010 Wicks, 2016, Diet-induced obesity and kidney disease - in search of a susceptible mouse model, Biochimie, 124, 65, 10.1016/j.biochi.2015.08.001 Herman-Edelstein, 2014, Altered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathy, J Lipid Res, 55, 561, 10.1194/jlr.P040501 Martinez-Garcia, 2015, Renal lipotoxicity-associated inflammation and insulin resistance affects actin cytoskeleton organization in podocytes, PLoS One, 10, e0142291, 10.1371/journal.pone.0142291 van der Heijden, 2015, Obesity-induced chronic inflammation in high fat diet challenged C57BL/6J mice is associated with acceleration of age-dependent renal amyloidosis, Sci Rep, 5, 16474, 10.1038/srep16474 Kume, 2007, Role of altered renal lipid metabolism in the development of renal injury induced by a high-fat diet, J Am Soc Nephrol, 18, 2715, 10.1681/ASN.2007010089 Lindholm, 2013, A high-fat diet decreases AMPK activity in multiple tissues in the absence of hyperglycemia or systemic inflammation in rats, J Physiol Biochem, 69, 165, 10.1007/s13105-012-0199-2 Decleves, 2011, AMPK mediates the initiation of kidney disease induced by a high-fat diet, J Am Soc Nephrol, 22, 1846, 10.1681/ASN.2011010026 Decleves, 2014, Regulation of lipid accumulation by AMP-activated kinase in high fat diet-induced kidney injury, Kidney Int, 85, 611, 10.1038/ki.2013.462 Stacchiotti, 2014, Mitochondrial and metabolic dysfunction in renal convoluted tubules of obese mice: protective role of melatonin, PLoS One, 9, e111141, 10.1371/journal.pone.0111141 Munusamy, 2015, Obesity-induced changes in kidney mitochondria and endoplasmic reticulum in the presence or absence of leptin, Am J Physiol Renal Physiol, 309, F731, 10.1152/ajprenal.00188.2015 Coughlan, 2016, Mapping time-course mitochondrial adaptations in the kidney in experimental diabetes, Clin Sci (Lond), 130, 711, 10.1042/CS20150838 Birk, 2013, The mitochondrial-targeted compound SS-31 re-energizes ischemic mitochondria by interacting with cardiolipin, J Am Soc Nephrol, 24, 1250, 10.1681/ASN.2012121216 Birk, 2014, Targeting mitochondrial cardiolipin and the cytochrome c/cardiolipin complex to promote electron transport and optimize mitochondrial ATP synthesis, Br J Pharmacol, 171, 2017, 10.1111/bph.12468 Szeto, 2014, Serendipity and the discovery of novel compounds that restore mitochondrial plasticity, Clin Pharmacol Ther, 96, 672, 10.1038/clpt.2014.174 Kang, 2014, Heterozygous SOD2 deletion impairs glucose-stimulated insulin secretion, but not insulin action, in high-fat-fed mice, Diabetes, 63, 3699, 10.2337/db13-1845 Thakur, 2006, Functional and structural renal changes in the early stages of obesity, Contrib Nephrol, 151, 135, 10.1159/000095325 Pusztaszeri, 2006, Immunohistochemical expression of endothelial markers CD31, CD34, von Willebrand factor, and Fli-1 in normal human tissues, J Histochem Cytochem, 54, 385, 10.1369/jhc.4A6514.2005 Schrijvers, 2004, The role of vascular endothelial growth factor (VEGF) in renal pathophysiology, Kidney Int, 65, 2003, 10.1111/j.1523-1755.2004.00621.x Pichaiwong, 2013, Reversibility of structural and functional damage in a model of advanced diabetic nephropathy, J Am Soc Nephrol, 24, 1088, 10.1681/ASN.2012050445 Reidy, 2014, Molecular mechanisms of diabetic kidney disease, J Clin Invest, 124, 2333, 10.1172/JCI72271 Mount, 2015, Obesity-related chronic kidney disease-the role of lipid metabolism, Metabolites, 5, 720, 10.3390/metabo5040720 Dong, 2011, Regulation of lipid droplets by autophagy, Trends Endocrinol Metab, 22, 234, 10.1016/j.tem.2011.02.003 Long, 2006, AMP-activated protein kinase signaling in metabolic regulation, J Clin Invest, 116, 1776, 10.1172/JCI29044 Reznick, 2006, The role of AMP-activated protein kinase in mitochondrial biogenesis, J Physiol, 574, 33, 10.1113/jphysiol.2006.109512 Nakayama, 2010, Endothelial von Willebrand factor release due to eNOS deficiency predisposes to thrombotic microangiopathy in mouse aging kidney, Am J Pathol, 176, 2198, 10.2353/ajpath.2010.090316 Abe, 2010, Bioenergetic characterization of mouse podocytes, Am J Physiol Cell Physiol, 299, C464, 10.1152/ajpcell.00563.2009 Boini, 2014, Activation of inflammasomes in podocyte injury of mice on the high fat diet: effects of ASC gene deletion and silencing, Biochim Biophys Acta, 1843, 836, 10.1016/j.bbamcr.2014.01.033 Zhao, 2004, Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury, J Biol Chem, 279, 34682, 10.1074/jbc.M402999200 Birk, 2015, Disruption of cytochrome c heme coordination is responsible for mitochondrial injury during ischemia, Biochim Biophys Acta, 1847, 1075, 10.1016/j.bbabio.2015.06.006 Sharma, 2013, Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease, J Am Soc Nephrol, 4, 1901, 10.1681/ASN.2013020126 Wojtczak, 1993, Effect of fatty acids on energy coupling processes in mitochondria, Biochim Biophys Acta, 183, 41, 10.1016/0005-2728(93)90004-Y Singh, 2009, Autophagy regulates lipid metabolism, Nature, 458, 1131, 10.1038/nature07976 Singh, 2011, Autophagy in the cellular energetic balance, Cell Metab, 13, 495, 10.1016/j.cmet.2011.04.004 Steinberg, 2006, Tumor necrosis factor alpha-induced skeletal muscle insulin resistance involves suppression of AMP-kinase signaling, Cell Metab, 4, 465, 10.1016/j.cmet.2006.11.005 Awad, 2015, Macrophage-derived tumor necrosis factor-alpha mediates diabetic renal injury, Kidney Int, 88, 722, 10.1038/ki.2015.162 Tang, 2012, Inflammation and oxidative stress in obesity-related glomerulopathy, Int J Nephrol, 2012, 608397, 10.1155/2012/608397 Szeto, 2011, Mitochondria-targeted peptide accelerates ATP recovery and reduces ischemic kidney injury, J Am Soc Nephrol, 22, 1041, 10.1681/ASN.2010080808 Mizuguchi, 2008, A novel cell-permeable antioxidant peptide decreases renal tubular apoptosis and damage in unilateral ureteral obstruction, Am J Physiol Renal Physiol, 295, F1545, 10.1152/ajprenal.00395.2007 Hou, 2016, Mitochondria-targeted peptide SS-31 attenuates renal injury via an antioxidant effect in diabetic nephropathy, Am J Physiol Renal Physiol, 310, F547, 10.1152/ajprenal.00574.2014 Dai, 2011, Mitochondrial targeted antioxidant peptide ameliorates hypertensive cardiomyopathy, J Am Coll Cardiol, 58, 73, 10.1016/j.jacc.2010.12.044 Liu, 2014, Novel cardiolipin therapeutic protects endothelial mitochondria during renal ischemia and mitigates microvascular rarefaction, inflammation, and fibrosis, Am J Physiol Renal Physiol, 306, F970, 10.1152/ajprenal.00697.2013 Eirin, 2014, Mitochondrial targeted peptides attenuate residual myocardial damage after reversal of experimental renovascular hypertension, J Hypertens, 32, 154, 10.1097/HJH.0b013e3283658a53 Eirin, 2012, A mitochondrial permeability transition pore inhibitor improves renal outcomes after revascularization in experimental atherosclerotic renal artery stenosis, Hypertension, 60, 1242, 10.1161/HYPERTENSIONAHA.112.199919 Eirin, 2014, Mitochondrial protection restores renal function in swine atherosclerotic renovascular disease, Cardiovasc Res, 103, 461, 10.1093/cvr/cvu157 Alam, 2015, A mitochondrial therapeutic reverses visual decline in mouse models of diabetes, Dis Model Mech, 8, 701, 10.1242/dmm.020248